Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ashland Inc.

www.ashland.com

Latest From Ashland Inc.

Asia Attracts Manufacturing Capital As Companies Eye Expanding Needs

Life science and pharma companies have been actively investing in Asia over the past month as they look to increase regional manufacturing capacities to tap into burgeoning markets and meet rising demand for new technologies, biologics and high-quality products, while Chinese firms have also been expanding their international presence.

Asia Pacific Manufacturing

Podcast: Preservatives Crisis Calls For Marketing Revolution

The cosmetic sector’s shrinking preservative palette calls for a dramatic marketing shift, according to industry veteran David Steinberg of Steinberg & Associates. In a May 11 interview, the cosmetic chemistry expert discussed movement away from proven preservative systems, implications for industry and consumer safety, and options for manufacturers intent on eschewing traditional preservatives, which are few and expensive.

Industry Reacts to Tough Excipient Regulations in China and Brazil

China is imposing tougher – and in some cases unrealistic – requirements for excipient manufacturers, while Brazil is proposing similar new requirements. Confusion abounds with respect to shelf life, expiration dates and retest dates.

BioPharmaceutical China

PASS Presses FDA To Repair TEA Process, Facilitate Sunscreen Reviews

The Public Access to SunScreens Coalition plans to work with FDA, lawmakers and stakeholders to facilitate review of sunscreen active ingredients. The group proposes user fees as one method of ensuring FDA has resources to complete sunscreen ingredient evaluations, some pending as time and extent applications since 2002.

Consumer United States
See All
UsernamePublicRestriction

Register